BNO 5.26% 20.0¢ bionomics limited

Thanks DDD. I sense there is some impatience. I didn't realise...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 593 Posts.
    lightbulb Created with Sketch. 24
    Thanks DDD. I sense there is some impatience. I didn't realise there was continuous selling going on but I should have guessed that from the SP.

    If it is any help, the "Agitation Study" should be pretty fast. It is only 40 subjects being recruited across 3 hospitals and it is 5 days of treatment (plus 2 days of follow up). All the measures are scores which tells me the results should be recorded as the scoring is done. That all adds up to quite a quick study. I'm not the type to read anything into that (others will) but if we see a flag from the company telling us that the recruitment phase is finished the results should be pretty quick to follow. However, they can be held up by "extensive analysis".

    The study started in May and the estimated completion is March next year. That seems a little out of kilter to me unless the number of possible recruits is exceedingly low (that may depend on the selectivity of the people recruiting the patients to be studied). Now, I understand that some people may think that March next year is not a fast result but I am hoping we might get something earlier than that. Certainly the end of the recruitment phase should be a very helpful guide.

    Having said that, I'd bet that something will be said regarding the PTSD study or a deal on oncology before the agitation study is completed. That's what I am expecting (and hoping for). GLTA
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.